share_log

Gemphire Therapeutics | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)

Gemphire Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)

美股SEC公告 ·  2006/11/29 05:48
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息